Table 2: D-CAP-18_31 MIC 2 mg/L against P. aeruginosa strain 121007
- Measure
- MIC
- Value
- 2 other
- Target
- Pseudomonas aeruginosa
- Assay
- Not reported by source
Antibiotics · 2025
Sequence evidence
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKL
Table 2: D-CAP-18_31 sequence Glrkrlrkfrnkikeklkkigqkiqgllpkl (lowercase = D-amino acids)
Experimental observations
Table 2: D-CAP-18_31 MIC 2 mg/L against P. aeruginosa strain 121007
Table 2: D-CAP-18_31 MIC 0.25 mg/L against P. aeruginosa ATCC 121110
Table 3: D-CAP-18_31 MIC50 4 mg/L against P. aeruginosa strain panel
Table 3: D-CAP-18_31 MIC90 16 mg/L against P. aeruginosa strain panel
Table 4: D-CAP-18_31 hemolysis IC50 108.44 uM against human erythrocytes
Table 4: D-CAP-18_31 cytotoxicity IC50 12.32 uM against A549 cells
Section 3: D-CAP-18_31 IC50 6.16 uM against HeLa cells (mentioned in discussion)
Table A1: D-CAP-18_31 MIC 0.25 mg/L against P. aeruginosa 12-1110 S1
Table A1: D-CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 21-0505 S2
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 21-0308 R2
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 15-0803 S3
Table A1: D-CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 15-0307 S4
Table A1: D-CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 21-0410 S5
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 16359347-2 R3
Table A1: D-CAP-18_31 MIC 2 mg/L against P. aeruginosa 36a
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 38a
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 27853
Table A1: D-CAP-18_31 MIC 16 mg/L against P. aeruginosa C1
Table A1: D-CAP-18_31 MIC 16 mg/L against P. aeruginosa C2
Table A1: D-CAP-18_31 MIC 8 mg/L against P. aeruginosa C3
Table A1: D-CAP-18_31 MIC 8 mg/L against P. aeruginosa C4
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa C5
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.